BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cardinale A, Calabrese V, de Iure A, Picconi B. Alpha-Synuclein as a Prominent Actor in the Inflammatory Synaptopathy of Parkinson's Disease. Int J Mol Sci 2021;22:6517. [PMID: 34204581 DOI: 10.3390/ijms22126517] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Ruan S, Xie J, Wang L, Guo L, Li Y, Fan W, Ji R, Gong Z, Xu Y, Mao J, Xie J. Nicotine alleviates MPTP-induced nigrostriatal damage through modulation of JNK and ERK signaling pathways in the mice model of Parkinson’s disease. Front Pharmacol 2023;14. [DOI: 10.3389/fphar.2023.1088957] [Reference Citation Analysis]
2 Ma Z, Liu K, Zhang R, Xie Z, Liu W, Deng Y, Li X, Xu B. Manganese-induced α-synuclein overexpression promotes the accumulation of dysfunctional synaptic vesicles and hippocampal synaptotoxicity by suppressing Rab26-dependent autophagy in presynaptic neurons. Science of The Total Environment 2023;858:159753. [DOI: 10.1016/j.scitotenv.2022.159753] [Reference Citation Analysis]
3 Al-Kuraishy HM, Al-Gareeb AI, Kaushik A, Kujawska M, Ahmed EA, Batiha GE. SARS-COV-2 infection and Parkinson's disease: Possible links and perspectives. J Neurosci Res 2023. [PMID: 36717481 DOI: 10.1002/jnr.25171] [Reference Citation Analysis]
4 Cardinale A, Calabrese V. The intricate debate on neurodegeneration and neuroinflammation in Parkinson’s disease: which came first? Neural Regen Res 2023;18:125. [DOI: 10.4103/1673-5374.343895] [Reference Citation Analysis]
5 Dening Y, Straßl T, Ruf V, Dirscherl P, Chovsepian A, Stievenard A, Khairnar A, Schmidt F, Giesert F, Herms J, Levin J, Dieterich M, Falkai P, Weisenhorn DV, Wurst W, Giese A, Pan-Montojo F. Toxicity of extracellular alpha-synuclein is independent of intracellular alpha-synuclein. Sci Rep 2022;12:21951. [PMID: 36535974 DOI: 10.1038/s41598-022-25790-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Emery DC, Davies M, Cerajewska TL, Taylor J, Hazell M, Paterson A, Allen-Birt SJ, West NX. High resolution 16S rRNA gene Next Generation Sequencing study of brain areas associated with Alzheimer's and Parkinson's disease. Front Aging Neurosci 2022;14:1026260. [PMID: 36570533 DOI: 10.3389/fnagi.2022.1026260] [Reference Citation Analysis]
7 Smit JW, Basile P, Prato MK, Detalle L, Mathy FX, Schmidt A, Lalla M, Germani M, Domange C, Biere AL, Bani M, Carson S, Genius J. Phase 1/1b Studies of UCB0599, an Oral Inhibitor of α-Synuclein Misfolding, Including a Randomized Study in Parkinson's Disease. Mov Disord 2022;37:2045-56. [PMID: 35959805 DOI: 10.1002/mds.29170] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Murphy J, Mckernan DP. The Effect of Aggregated Alpha Synuclein on Synaptic and Axonal Proteins in Parkinson’s Disease—A Systematic Review. Biomolecules 2022;12:1199. [DOI: 10.3390/biom12091199] [Reference Citation Analysis]
9 Imbriani P, Martella G, Bonsi P, Pisani A. Oxidative stress and synaptic dysfunction in rodent models of Parkinson's disease. Neurobiol Dis 2022;173:105851. [PMID: 36007757 DOI: 10.1016/j.nbd.2022.105851] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Forloni G, La Vitola P, Balducci C. Oligomeropathies, inflammation and prion protein binding. Front Neurosci 2022;16:822420. [DOI: 10.3389/fnins.2022.822420] [Reference Citation Analysis]
11 Huang J, Li C, Shang H. Astrocytes in Neurodegeneration: Inspiration From Genetics. Front Neurosci 2022;16:882316. [DOI: 10.3389/fnins.2022.882316] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Miller SJ, Campbell CE, Jimenez-corea HA, Wu G, Logan R. Neuroglial Senescence, α-Synucleinopathy, and the Therapeutic Potential of Senolytics in Parkinson’s Disease. Front Neurosci 2022;16:824191. [DOI: 10.3389/fnins.2022.824191] [Reference Citation Analysis]
13 Dening Y, Straßl T, Ruf V, Dirscherl P, Chovsepian A, Stievenard A, Khairnar A, Schmidt F, Giesert F, Herms J, Levin J, Dieterich M, Falkai P, Weisenhorn DV, Wurst W, Giese A, Pan-montojo F. Toxicity of extracellular alpha-synuclein is independent of intracellular alpha-synuclein.. [DOI: 10.1101/2022.03.31.486401] [Reference Citation Analysis]
14 Mamais A, Kaganovich A, Harvey K. Convergence of signalling pathways in innate immune responses and genetic formof Parkinson’s disease. Neurobiology of Disease 2022. [DOI: 10.1016/j.nbd.2022.105721] [Reference Citation Analysis]
15 Gitto R, Vittorio S, Bucolo F, Peña-Díaz S, Siracusa R, Cuzzocrea S, Ventura S, Di Paola R, De Luca L. Discovery of Neuroprotective Agents Based on a 5-(4-Pyridinyl)-1,2,4-triazole Scaffold. ACS Chem Neurosci 2022;13:581-6. [PMID: 35179861 DOI: 10.1021/acschemneuro.1c00849] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Amin J, Erskine D, Donaghy PC, Surendranathan A, Swann P, Kunicki AP, Boche D, Holmes C, Mckeith IG, O'brien JT, Teeling JL, Thomas AJ. Inflammation in dementia with Lewy bodies. Neurobiology of Disease 2022. [DOI: 10.1016/j.nbd.2022.105698] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Domingues R, Sant’anna R, da Fonseca ACC, Robbs BK, Foguel D, Outeiro TF. Extracellular alpha-synuclein: Sensors, receptors, and responses. Neurobiology of Disease 2022. [DOI: 10.1016/j.nbd.2022.105696] [Reference Citation Analysis]
18 Takahashi S, Mashima K. Neuroprotection and Disease Modification by Astrocytes and Microglia in Parkinson Disease. Antioxidants 2022;11:170. [DOI: 10.3390/antiox11010170] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
19 Sun Z, Song L, Li J. Knockdown of small nucleolar RNA host gene 10 (SNHG10) alleviates the injury of human neuroblastoma cells via the miR-1277-5p/insulin substrate receptor 2 axis. Bioengineered 2022;13:709-20. [DOI: 10.1080/21655979.2021.2012623] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Behl T, Kaur I, Sehgal A, Singh S, Bhatia S, Al-Harrasi A, Zengin G, Bumbu AG, Andronie-Cioara FL, Nechifor AC, Gitea D, Bungau AF, Toma MM, Bungau SG. The Footprint of Kynurenine Pathway in Neurodegeneration: Janus-Faced Role in Parkinson's Disorder and Therapeutic Implications. Int J Mol Sci 2021;22:6737. [PMID: 34201647 DOI: 10.3390/ijms22136737] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]